Leonela Amoasii PhD

Leonela Amoasii, Ph.D., has worked in the laboratory of Dr. Eric Olson at the University of Texas Southwestern Medical Center in Dallas since 2012. Dr. Amoasii obtained her undergraduate degree in Molecular Biology and Biochemistry and master degree in Molecular and Cellular Physiopathology at the Louis Pasteur University in Strasbourg, France. Dr. Amoasii pursued her graduate studies at the Institut de Génétique Biologie Moléculaire et Cellulaire (IGBMC) at the University of Strasbourg in France.

During her doctoral studies, she identified the mechanistic basis of myotubular centronuclear myopathy and acquired expertise in the use of adeno-associated virus (AAV) for manipulation of gene expression in muscle. Over the last years, Dr. Amoasii has been involved in developing a new therapeutic approach for repairing Duchenne muscular dystrophy using CRISPR/Cas9 genomic editing. Dr. Amoasii pursued the in vivo optimization of the CRISPR/Cas9 genomic editing, her recent work reveals promising results for translation of the genome editing technology to human patients.